Browsing: Health

By Atharva Singh and Arasu Kannagi Basil Feb 5 (Reuters) – Drug developer Eikon Therapeutics, headed by Merck veteran Roger…

Subsidies. Love ’em or hate them, they dominated the news during the Affordable Care Act’s sign-up season, and their reduction…

SHANGHAI, March 6 (Reuters) – China has approved Pfizer’s GLP-1 treatment Xianweiying for long-term weight management ‌in overweight or obese…

By Alexander Marrow LONDON, March 11 (Reuters) – Haleon is stepping up its Chinese expansion, pushing into second- and third-tier…

By Sriparna Roy March 18 (Reuters) – The U.S. Food and Drug Administration has approved Johnson & Johnson’s oral pill…

March 19 (Reuters) – Eli Lilly’s next-generation obesity drug showed a reduction in blood sugar levels during a late-stage trial,…

March 20 (Reuters) – U.S. consumer health products maker Prestige Consumer Healthcare said on ‌Friday it would buy the Breathe…

By Deena Beasley LOS ANGELES (Reuters) — Amgen (AMGN) on Monday launched direct-to-consumer U.S. sales of its cholesterol-lowering medication Repatha…

By Stine Jacobsen, Jacob Gronholt-Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Novo Nordisk’s top investor moved to take control of the…

By Sneha S K (Reuters) -Molina Healthcare shares fell 18% in premarket trading on Thursday, a day after the insurer…